The Journal of Immunology, Vol 157, Issue 8 3334-3340, Copyright © 1996 by American Association of Immunologists

ARTICLES

Defective B cell development in Snell dwarf (dw/dw) mice can be corrected by thyroxine treatment

E Montecino-Rodriguez, R Clark, A Johnson, L Collins and K Dorshkind
Division of Biomedical Sciences, University of California, Riverside 92521, USA.

Snell dwarf (dw/dw) mice are deficient in anterior pituitary hormones due to a mutation in the gene encoding the Pit-1 transcription factor. Bone marrow B cell development is also suppressed in the mice, providing circumstantial evidence that one or more anterior pituitary- derived products, or factors induced by them, are required for normal B lymphopoiesis. However, concluding that this is the case is dependent on showing that hormonal treatment of dwarf mice reverses their B cell defects. dw/dw mice were treated with growth hormone (GH), insulin-like growth factor-I (IGF-I), or thyroxine in an attempt to restore bone marrow B lymphopoiesis. GH and IGF-I increased the number of B lineage cells in the bone marrow and spleen but did not restore the frequency of bone marrow pre-B cells to normal. However, bone marrow cellularity in thyroxine-treated dw/dw mice was comparable to that in control animals, and both the frequency and absolute number of B lineage cells had increased to normal or even above normal. Taken together, these data indicate that endocrine factors, especially those regulated by the hypothalamic-pituitary-thyroid axis, are potent B lymphopoietic factors.

This article has been cited by other articles:

				L. A. Welniak, R. Sun, and W. J. Murphy The role of growth hormone in T-cell development and reconstitution J. Leukoc. Biol., March 1, 2002; 71(3): 381 - 387. [Abstract] [Full Text] [PDF]

				L. Welniak, S. Richards, and W. Murphy Effects of prolactin on hematopoiesis Lupus, October 1, 2001; 10(10): 700 - 705. [Abstract] [PDF]

				K. Dorshkind and N. D. Horseman The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency Endocr. Rev., June 1, 2000; 21(3): 292 - 312. [Abstract] [Full Text]

				S. Okada, T. Yoshida, Z. Hong, G. Ishii, M. Hatano, M. Kuro-o, Y. Nabeshima, Y.-i. Nabeshima, and T. Tokuhisa Impairment of B lymphopoiesis in precocious aging (klotho) mice Int. Immunol., June 1, 2000; 12(6): 861 - 871. [Abstract] [Full Text] [PDF]

				C. R. Vines and D. A. Weigent Identification of SP3 as a Negative Regulatory Transcription Factor in the Monocyte Expression of Growth Hormone Endocrinology, March 1, 2000; 141(3): 938 - 946. [Abstract] [Full Text] [PDF]

				C. Arpin, M. Pihlgren, A. Fraichard, D. Aubert, J. Samarut, O. Chassande, and J. Marvel Effects of T3R{alpha}1 and T3R{alpha}2 Gene Deletion on T and B Lymphocyte Development J. Immunol., January 1, 2000; 164(1): 152 - 160. [Abstract] [Full Text] [PDF]

				M. P. Foster, E. Montecino-Rodriguez, and K. Dorshkind Proliferation of Bone Marrow Pro-B Cells Is Dependent on Stimulation by the Pituitary/Thyroid Axis J. Immunol., December 1, 1999; 163(11): 5883 - 5890. [Abstract] [Full Text] [PDF]

				B. Bouchard, C. J. Ormandy, J. P. Di Santo, and P. A. Kelly Immune System Development and Function in Prolactin Receptor-Deficient Mice J. Immunol., July 15, 1999; 163(2): 576 - 582. [Abstract] [Full Text] [PDF]

				G. Smithson, J. F. Couse, D. B. Lubahn, K. S. Korach, and P. W. Kincade The Role of Estrogen Receptors and Androgen Receptors in Sex Steroid Regulation of B Lymphopoiesis J. Immunol., July 1, 1998; 161(1): 27 - 34. [Abstract] [Full Text] [PDF]

				R. Clark The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function Endocr. Rev., April 1, 1997; 18(2): 157 - 179. [Abstract] [Full Text]